About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
ASCO® 2023 Insights: "Chemo +/- IO for Mesothelioma"
By
GRACE
FEATURING
Jack West
,
Christine Lovly
,
Alfredo Addeo
By
GRACE
FEATURING
Jack West
,
Christine Lovly
,
Alfredo Addeo
52 views
July 21, 2023
0 Comments
Login to view comments.
Click here to Login
Featured Video
09:36
Johnson & Johnson
Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…
Feat.
J. Heymach,
M. Das
Featured Video
06:27
Johnson & Johnson
Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC
Feat.
M. Socinski,
D. Waterhouse
Related Content
AUTOPLAY
ON
36:14
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …
Feat.
B. Halmos
22:27
2024 ASCO® Annual Meeting Insights Hub
Developmental Therapeutics Highlights From ASCO® 2024
Feat.
G. Sonpavde
12:10
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "BEAT Trials and Neoadjuvant Strategies - A…
Feat.
M. Marmarelis
04:35
Total Health
Chemo vs. Chemo + Pembro in 1L Pleural Mesothelioma - 2023 ASCO® Dir…
Feat.
J. Bauman
08:29
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "MIST5 Trial - Niraparib & Dostarlimab…
Feat.
D. Fennell
15:37
ImmunoTherapy Bridge 2023
What’s New in NSCLC & Mesothelioma Immunotherapy
Feat.
A. Morabito
11:28
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "ETOP 13-18 BEAT-meso Trial - Bevacizumab …
Feat.
S. Popat
10:31
MI&T Congressi
Immunotherapy for Patients With Mesothelioma
Feat.
J. Aerts
08:14
2023 Texas Lung Cancer Conference Coverage
Updates in Malignant Pleural Mesothelioma
Feat.
M. Marmarelis
22:02
OncoAlert
Significant Advances in Mesothelioma
Feat.
G. Mountzios
09:04
Oncology Data Advisor
Discovering Research Advances in Mesothelioma
Feat.
S. Kareff,
E. Rodriguez
07:11
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "First Survival Data From the NIPU Trial - …
Feat.
A. Helland
09:57
ILCC 2022 Conference Coverage
ILCC 2022 Mesothelioma: Updates in Systemic Therapy
Feat.
P. Baas
08:40
Laura Ridolfi
MESOVAX Clinical Trial of Pembro & Dendritic Cell Vaccine in Adv…
15:09
Oncology Data Advisor
World Lung Cancer Day: Key Insights and Advances in Lung Cancer Trea…
Feat.
S. Kareff,
B. Sandy,
M. Vojnic
05:22
ecancer
ESMO 2021 Updates on 1L Nivo+Ipi for Unresectable Malignant Pleural …
Feat.
S. Peters
04:33
ecancer
ASCO® 2023 Insights: "Pembro in 1L Treatment for Unresectable A…
Feat.
P. Bradbury
09:56
2020 Virtual ESMO Review
2020 ESMO Updates in Lung Cancer: Does 1L Nivolumab–Ipilimumab Boost…
Feat.
M. Dietrich
16:56
WCLC 2022 Conference Coverage
WCLC 2022 on Ipilimumab and Nivolumab in Pretreated Patients With Ma…
Feat.
M. Jakopovic
17:52
Memorial Sloan Kettering Cancer Center
Malignant Pleural Mesothelioma: What Do Clinical Trials Suggest on A…
Feat.
M. Zauderer